γ-Glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults

Obesity

Volumn 17, Issue 4, 2009, Pages 809-813

  Li, Ming ^a   Campbell, Sandra ^a   McDermott, Robyn ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUSTRALIA; BLOOD; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; ETHNIC AND RACIAL GROUPS; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADULT; AUSTRALIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; POPULATION GROUPS; RISK FACTORS; TRIGLYCERIDES;

NICOTIANA TABACUM;

EID: 63049104747     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.617     Document Type: Article

References (27)

1. McCarty D, Zimmet P, Dalton A, Segal L, Welborn T. The Rise and Rise of Diabetes in Australia, 1996: A Review of Statistics, Trends and Costs. International Diabetes Institute & Diabetes: Canberra, Australia, 1996.
2. Thow A, Waters A. Diabetes in Culturally and Linguistically Diverse Australians: Identification of Communities at High Risk. Australian Institute of Health and Welfare: Canberra, 2005.
3. Leonard D, McDermott R, O'Dea K et al. Obesity, diabetes and associated cardiovascular risk factors among Torres Strait Islander people. Aust N Z J Public Health 2002;26:144-149.
4. Daniel M, Rowley KG, McDermott R, Mylvaganam A, O'Dea K. Diabetes incidence in an Australian aboriginal population. Diabetes Care 1999;22:1993-1998.
5. Magliano DJ, Barr EL, Zimmet PZ et al. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian diabetes, obesity and lifestyle study. Diabetes Care 2008;31:267-272.
6. Perry IJ, Wannamethee GS, Shaper GA. Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732-737.
7. Lee DH, Silventoinen K, Jacobs DR, Jousilahti P, Tuomileto J. γ-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 2004;89:5410-5414.
8. Nakanishi N, Suzuki K, Tatara K. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004;27:1427-1432.
9. Wallach J. Interpretation of Diagnostic Tests. Lippincott Williams & Wilkins: Philadelphia, 2000.
10. Manual of Use and Interpretation of Pathology Tests. The Royal College of Pathologists of Australasia: Sydney, 1997.
11. Seppala-Lindroos A, Vehkavaara S, Hakkinen A-M et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002;87:3023-3028.
12. Czaja MJ. Liver injury in the setting of steatosis: crosstalk between adipokine and cytokine. Hepatology 2004;40:19-22.
13. Hui JM, Hodge A, Farrell GC et al. Beyond insulin resistance in NASH: TNF-α or adiponectin? Hepatology 2004;40:46-54.
14. Tiikkainen M, Tamminen M, Hakkinen A-M et al. Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obesity 2002;10:859-867.
15. McMillan KP, Kurk JL, Church TS, Blair SN, Ross R. Independent association between liver fat, visceral adipose tissue, and metabolic risk factors in men. Appl Physiol Nutr Metab 2007;32:265-272.
16. Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007;30:2940-2944.
17. Lawlor DA, Sattar N, Smith GD, Ebram S. The association of physical activity and adiposity with alanine aminotransferase and γ- glutamyltransferase. Am J Epidemiol 2005;161:1081-1088.
18. Perseghin G, Lattuada G, Cobelli FD et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 2007;30:683-688.
19. Miller G, McDermott R, McCulloch B et al. The Well Person's Health Check: a population screening program in indigenous communities in North Queensland, Aust Health Rev 2002;25:136-147.
20. International Diabetes Institute: Diabesity and Associated Disorders in Australia: 2000. International Diabetes Institute: Melbourne, 2001.
21. World Health Organization. Part 1: diagnosis and classification of diabetes mellitus. In: Definition, diagnosis and classification of diabetes mellitus and its complications. Department of Noncommunicable Disease Surveillance, WHO: Geneva, 1999.
22. Alberti K, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
23. Haskell WL, Lee I-M, Pate RR et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007;39:1423-1434.
24. World Health Organization. Obesity - Preventing and Managing the Global Epidemic: Report of a WHO Expert Committee. World Health Organization: Geneva, 1998.
25. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome 〈http://www.bibalex.org/Supercourse/metabolic/ IDF1.pdf〉.
26. National Heart Lung and Blood Institute. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285: 2486-2497.
27. Jeon C, Lokken R, Hu F, Dam RV. Physical activity of moderate intensity and risk of Type 2 diabetes - a systematic review. Diabetes Care 2007;30:744-752.